Clinical challenges of perimenopause: Consensus opinion of the North American Menopause Society

Menopause

Volumn 7, Issue 1, 2000, Pages 5-13

  Rebar, Robert W ^a   Nachtigall, Lila E ^b   Avis, Nancy E ^c   Kronenberg, Fredi ^d   Santoro, Nanette F ^e   Sowers, Mary Fran ^f   Archer, David F ^g  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g CENTER FOR PEDIATRIC RESEARCH   (United States)

Author keywords

Menopause transition; NAMS consensus opinion; Perimenopause

Indexed keywords

ESTROGEN;

EVIDENCE BASED MEDICINE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MEDICAL EXAMINATION; MENOPAUSE; PATIENT COUNSELING; PHYSICAL EXAMINATION; REVIEW; SCREENING TEST; SYMPTOMATOLOGY;

EID: 0033970805     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200007010-00003     Document Type: Review

References (68)

1. Boggs PP, Utian WH. The North American Menopause Society develops consensus opinions [Editorial]. Menopause 1998;5:67-8.
2. Bonadonna G, Valagussa P, Rossi A, et al. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 1985;5:95-115.
3. Richards MA, O'Reilly SM, Howell A, et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester Trial. J Clin Oncol 1990;8:2032-9.
4. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985;103:350-6.
5. Brambilla DJ, McKinlay SM. A prospective study of factors affecting age at menopause. J Clin Epidemiol 1989;42:1031-9.
6. Ravn P, Lind C, Nilas L. Lack of influence of simple premenopausal hysterectomy on bone mass and bone metabolism. Am J Obstet Gynecol 1995;172:891-5.
7. World Health Organization. Research on the menopause in the 1990s: report of a WHO scientific group. Geneva: WHO Technical Report Series 866; 1996.
8. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231-7.
9. Lenton EA, Landgren BM, Sexton L, Harper R. Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol 1984;91:681-4.
10. Metcalf MG, Livesey JH. Gonadotropin excretion in fertile women: effect of age and the onset of the menopausal transition. J Endocrinol 1985;105:357-62.
11. Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988;3:851-5.
12. Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80:3537-45.
13. Lenton EA, Sexton L, Lee S, Cooke ID. Progressive changes in LH and FSH and LH:FSH ratios in women throughout reproductive life. Maturitas 1988;10:35-43.
14. Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function before, during and after menopause: a longitudinal study. Clin Endocrinol 1982;17:489-94.
15. Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81:1495-501.
16. Stellate RK, Crawford SL, McKinlay SM, Longcope CL. Can follicle-stimulating hormone be used to define menopausal status? Endocr Pract 1998;4:137-41.
17. Rebar RW, Cedars MI, Liu JH. Premature ovarian failure: a model for the menopause? In: Lobo RA, ed. Perimenopause. New York: Springer-Verlag, 1997:7-11.
18. McKinlay SM, Brambilla PJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103-15.
19. Greendale GA, Sowers MF. The menopause transition. Endocrinol Metab Clin North Am 1997;26:261-77.
20. Treolar AE, Bonton RE, Behn BG, et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967;12:77-127.
21. Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975;55:699-706.
22. van Look PF, Lothian H, Hunter W, Michie E, Baird D. Hypothalamic-pituitary-ovarian function in perimenopausal women. Clin Endocrinol 1977;7:13-31.
23. Awwad JT, Toth TL, Schiff I. Abnormal uterine bleeding in the perimenopause. Int J Fertil Menopausal Stud 1993;38:261-9.
24. Gambrell RD Jr. Strategies to reduce the incidence of endometrial cancer in postmenopausal women. Am J Obstet Gynecol 1997;177:1196-204; discussion 1204-7.
25. Casper RF, Dodin S, Reid RL. The effect of 20 micrograms ethinyl estradiol/1 mg norethindrone acetate (Minestrin™), a low dose oral contraceptive, on vaginal bleeding patterns, hot flashes and quality of life in symptomatic perimenopausal women. Menopause 1997;4:139-47.
26. Archer DF. Medical management of menorrhagia in pre-and perimenopausal women. In: Lobo RA, ed. Perimenopause, Serono Symposia USA. New York: Springer-Verlag, 1997:271-80.
27. Mishell DR. Abnormal uterine bleeding: combined treatment approaches. Menopause Management 1994;3(5):24-8.
28. Kiningham RB, Apgar BS, Schwenk TL. Evaluation of amenorrhea. Am Fam Physician 1996;53:1185-94.
29. Screening for thyroid disease. In: Guide to clinical preventive services. Report of the US Preventive Services Task Force. Baltimore: Williams & Wilkins, 1989:71-5.
30. First MB, Frances A. DSM-IV handbook of differential diagnosis. Washington, DC: American Psychiatric Association, 1995.
31. Pearlstein TB. Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 1995;173:646-53.
32. McKinlay SM, Jefferys M. The menopausal syndrome. Br J Prev Soc Med 1974;28:108-15.
33. Thompson B, Hart SA, Durno D. Menopausal age and symptomatology in a general practice. J Biosoc Sci 1973;5:71-82.
34. Kronenberg F. Hot flashes. In: Lobo RA, ed. Treatment of the postmenopausal woman: basic and clinical aspects. New York: Raven Press, 1994:97-114.
35. Lock M. Menopause in cultural context. Exp Gerontol 1994;29:307-17.
36. Pham KTC, Freeman EW, Grisso JA. Menopause and hormone replacement therapy: focus groups of African-American and Caucasian women. Menopause 1997;4:71-9.
37. Kronenberg F, Downey JA. Thermoregulatory physiology of menopausal hot flashes: a review. Can J Physiol Pharmacol 1987;65:1312-24.
38. Campbell S, Whitehead M. Oestrogen therapy and the menopause syndrome. Clin Obstet Gynaecol 1977;4:31-47.
39. Sonnendecker EW, Polakow ES. Effects of conjugated equine estrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure, and endocrinological indices. S Afr Med J 1980;77:281-5.
40. Steingold KA, Laufer L, Chetkowski RJ, et al. Treatment of hot flashes with transdermal estradiol administration. J Clin Endocrinol Metab 1985;61:627-32.
41. Haas S, Walsh B, Evans S, Krache M, Ravnikar V, Schiff I. The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period. Obstet Gynecol 1988;71:671-6.
42. Regestein QR. Menopausal aspects of sleep disturbance. In: Lorrain J, Plouffe L Jr, Ravnikar VA, et al., eds. Comprehensive management of menopause. New York: Springer-Verlag, 1994:358-66.
43. Bachmann GA. The changing vagina: treating atrophy and infection. Menopause Management 1993;2(1):31-4.
44. Kaufman RH, Friedrich EG Jr, Gardner HL. Atrophic, desquamated, and postradiation vulvovaginitis. In: Benign diseases of the vulva and vagina, 3rd ed. Chicago: Year Book Medical Publishers, 1989:419-24.
45. Bergh P. Vaginal changes with aging. In: Breen JL, ed. The gynecologist and the older patient. Rockville: Aspen Publications, 1988:299-311.
46. Semmens JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982;248:445-8.
47. Tsai CC, Semmens JP, Semmens EC, Lam CF, Lee FS. Vaginal physiology in postmenopausal women: pH value, transvaginal electropotential difference, and estimated blood flow. South Med J 1987;80:987-90.
48. Sampselle CM, Burns PA, Dougherty MC, Newman DK, Thomas KK, Wyman JF. Continence for women: evidence-based practice. J Obstet Gynecol Neonatal Nurs 1997;26:375-85.
49. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990;592:52-86; discussion 123-33.
50. Freedman RR, Woodward SW. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992;167:436-9.
51. Israel D, Youngkin EQ. Herbal therapies for perimenopausal and menopausal complaints. Pharmacotherapy 1997;17:970-84.
52. Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997;68:981-6.
53. Wyon Y, Lindgren R, Lundeberg T, Hammar M. Effects of acupuncture on climacteric vasomotor symptoms, quality of life, and urinary excretion of neuropeptides among postmenopausal women. Menopause 1995;2:3-12.
54. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999;6:7-13.
55. Heaps J. HRT and its impact on ovarian cancer, colon cancer and more. Presented at Menopause Management 1997: In Search of a Consensus. Anaheim, CA, September 26-28, 1997.
56. Postmenopausal hormone prophylaxis. In: Guide to clinical preventive services: report of the US Preventive Services Task Force, 2nd ed. Baltimore: Williams & Wilkins, 1996:829-43.
57. Speroff L, Whitcomb RW, Kempfert NJ, Boyd RA, Paulissen JB, Rowan JP. Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms. Obstet Gynecol 1996;88:587-92.
58. De Leo V, Lanzetta D, Morgante G, De Palma P, D'Antona D. Inhibition of ovulation with transdermal estradiol and oral progestogens in perimenopausal women. Contraception 1997;55:239-43.
59. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994;331:347-52.
60. Walsh B, Schiff I. Vasomotor flushes. Ann N Y Acad Sci 1990;592:346-56.
61. Polo-Kantola P, Erkkola R, Helenins H, Irjala K, Polo O. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 1998;178:1002-9.
62. Coope J. Hormonal and non-hormonal interventions for menopausal symptoms. Maturitas 1996;23:159-68.
63. Dei M, Verni A, Bigozzi L, Bruni V. Sex steroids and libido. Eur J Contracept Reprod Health Care 1997;2:253-8.
64. Gassman A, Santoro N. The influence of menopausal hormone changes on sexuality: current knowledge and recommendations for practice. Menopause 1994;1:91-8.
65. Gise LH. What you can do about depression at menopause. Menopausal Med 1996;4(1):1-5.
66. Pasnau R, ed. Diagnosis and treatment of anxiety disorders. Washington: American Psychiatric Press, 1984.
67. Rosenthal M, O'Grady JP. Affective and anxiety disorders. In: Obstetrics: psychological and psychiatric syndromes. New York: Elsevier, 1992:109-38.
68. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease [see comments], N Engl J Med 1996;335:453-61 [published erratum appears in N Engl J Med 1996;335:1406].